Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas

BACKGROUND: Patients with non-small cell lung cancer (NSCLC) harboring a ROS proto-oncogene 1 (ROS1)-rearrangement respond to treatment with ROS1 inhibitors. To distinguish these rare cases, screening with immunohistochemistry (IHC) for ROS1 protein expression has been suggested. However, the reliab...

Descripción completa

Detalles Bibliográficos
Autores principales: Thurfjell, Viktoria, Micke, Patrick, Yu, Hui, Krupar, Rosemarie, Svensson, Maria A., Brunnström, Hans, Lamberg, Kristina, Moens, Lotte N. J., Strell, Carina, Gulyas, Miklos, Helenius, Gisela, Yoshida, Akihiko, Goldmann, Torsten, Mattsson, Johanna Sofia Margareta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830269/
https://www.ncbi.nlm.nih.gov/pubmed/36636421
http://dx.doi.org/10.21037/tlcr-22-504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830269/
https://www.ncbi.nlm.nih.gov/pubmed/36636421
http://dx.doi.org/10.21037/tlcr-22-504

Ejemplares similares